Home › Multiple Sclerosis › Ohio
Multiple Sclerosis clinical trials in Ohio
14 studies for Multiple Sclerosis are looking for participants at sites in Ohio.
Cities in Ohio
A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
- Local Institution - Site 104, Columbus
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Sep 25, 2026 · NCT07840326A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Centerville
- TG Therapeutics Investigational Trial Site, Centerville
- TG Therapeutics Investigational Trial Site, Cincinnati
- and 4 more
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT06433752Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Ohio State University Comprehensive Cancer Center, Columbus
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
- University of Cincinnati, Cincinnati
RecruitingPhase 1/2
Ages 18 to 65 · All sexes · Updated Sep 21, 2026 · NCT07477639Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- The Ohio State University- Site Number : 8400009, Columbus
- The Boster Center for Multiple Sclerosis- Site Number : 8400006, Columbus
RecruitingPhase 3
Ages 18 to 60 · All sexes · Updated Sep 15, 2026 · NCT07325292RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Cleveland Clinic, Cleveland
- The Ohio State University, Department of Psychiatry, Columbus
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 15, 2026 · NCT07002034A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
- University of Cincinnati Medical Center, Cincinnati
- Riverside Methodist Hospital, Columbus
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Sep 9, 2026 · NCT06782490A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- TG Therapeutics Investigational Trial Site, Cleveland
- TG Therapeutics Investigational Trial Site, Columbus
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06680037An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
- Research Site, Cleveland
RecruitingPhase 1
Ages 18 to 60 · All sexes · Updated Aug 25, 2026 · NCT07224373Electrical Stimulation Exercise for Individuals With Lower Limb Paralysis
- Louis Stokes Cleveland VA Medical Center, Cleveland
Recruiting
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT07768761Understanding and Enhancing Human Health and Movement
- Louis Stokes Cleveland VA Medical Center, Cleveland
Recruiting
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT07738978Care in Multiple Sclerosis (MS)
- Cleveland Clinic, Cleveland
RecruitingObservational study
Ages 18 and older · All sexes · Updated May 5, 2026 · NCT07011914Central Vein Sign in Multiple Sclerosis Extension Study
- Cleveland Clinic Foundation, Cleveland
Recruiting
Ages 18 to 65 · All sexes · Updated Feb 20, 2026 · NCT07424027Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
- Cleveland State University, Cleveland
Recruiting
Ages 22 to 75 · All sexes · Updated Sep 24, 2025 · NCT05964829From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.